Vanutide cridificar Antibody
Vanutide cridificar (ACC-001) is a conjugate of the N-terminal Aβ1-7 peptide, used in Alzheimer's disease research. It has been investigated in clinical trials as an immunotherapeutic vaccine candidate to induce antibodies targeting amyloid-beta for both in vivo and in vitro experimental applications.
Product Specifications
Target
Beta Amyloid
Conjugation
Unconjugated
Field of Research
Neuroscience
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
